NOW OPEN Rutgers Cancer Institute: “A Phase I Trial of T Cell Receptor Gene Therapy Targeting KK-LC-1 for Cancers of the Stomach, Breast, Lung and Cervix.” #ClinicalTrial #CancerResearch Christian Hinrichs RWJBarnabas cinj.org/clinical-trial…

A big thank you to Rutgers W.Basketball coach Coquese Washington Coquese Washington and Rutgers W.Basketball Chief of Staff Stephen Fishler Stephen Fishler for visiting us at Rutgers Cancer Institute today! 🏀
RWJBarnabas Rutgers Scarlet Knights Andrew M. Evens, DO, MBA, MSc Steven Libutti

NOW OPEN RutgersCancerInstNJ: “A Phase II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers” Christian Hinrichs #ClinicalTrial #CancerResearch RWJBarnabas cinj.org/clinical-trial…

NOW OPEN Rutgers Cancer Institute: “A Phase I Trial of T Cell Receptor Gene Therapy Targeting KK-LC-1 for Cancers of the #Stomach , #Breast , #Lung and Cervix.” #ClinicalTrial #CancerResearch Christian Hinrichs RWJBarnabas #BCSM cinj.org/clinical-trial…

NOW OPEN Rutgers Cancer Institute: “A Phase I Trial of T Cell Receptor Gene Therapy Targeting KK-LC-1 for Cancers of the Stomach, Breast, Lung and Cervix.” #ClinicalTrial #CancerResearch Christian Hinrichs RWJBarnabas cinj.org/clinical-trial…

NOW OPEN RutgersCancerInstNJ: “A Phase II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers” Christian Hinrichs

#ClinicalTrial #CancerResearch #HPV #hpvvaccine RWJBarnabas

ow.ly/fuwc50O9f7e

In this Perspective, we consolidate lessons from clinical experience and describe key issues going forward in the development of cell therapy for epithelial cancers. sciencedirect.com/science/articl…

Thanks to Tracie Saunders RN, OHRS Exec Dir reporting on our new cellular therapy #clinicaltrials for solid tumors, working with Dr ⁦Christian Hinrichs⁩. Latest in TCR cell therapy now ⁦Rutgers Cancer Institute⁩ ⁦RWJBarnabas⁩

Work by John Davies finding in multiple solid tumor T cell therapy models that PD-1 blockade acts through endogenous rather than transferred T cells to mediate a non-synergistic anti-tumor effect. It will be interesting to see clinical data from the many active studies.

NCI Division of Cancer Biology 1/2 Cell Therapy, approved for heme malignancies, is now demonstrating activity in solid tumors. Our collaboration with Christian Hinrichs has demonstrated amazing response rates in #HPV associated cancers with TCR engineered T-cells.
nature.com/articles/s4159…
#CIM22 #CIMChat22

What a great honor to celebrate with so many friends!

🙌 A big welcome to Ira Braunschweig, MD, as the new Chief of the Section of Transplant and Cell Therapy at Rutgers Cancer Institute & Chief of the Transplant and Cell Therapy Service at RWJBarnabas Oncology Service Line: cinj.org/new-chief-bone….

#CellTherapy #BMT #LetsBeatCancerTogether

From diagnosis, to treatment, to survivorship, the Rutgers Cancer Institute RWJBarnabas Jack & Sheryl Morris Cancer Center will serve as a beacon of hope & destination for those who need it most. The 12 story, 510,000 s.f. facility is set for completion in 2024! cinj.org/about-cinj/jac…

#ASHKudos to Robert Wood Johnson University Hospital RutgersCancerInstNJ Heme/Onc fellow Dr Jiequi (Janice) Liu for leading the multicenter RWE project of CD19 #CART Therapy in Solid Organ Transplant (SOT)-Related #PTLD ; it provides the largest analysis to date of CD19 CAR-T SOT-related PTLD.

ash.confex.com/ash/2021/webpr…

.Rutgers Cancer Institute is seeking a nationally recognized research-focused pathologist to serve as the Chief of Cancer Pathology and Director of the Biorepository &Histopathology Service at Rutgers Cancer Institute. For more details please visit: jobs.rutgers.edu/postings/133814

Excited to share our work on the potential role of preventative immunotherapy in high risk oral leukoplakia 🧐👀🩺 Dana-Farber News Ravi Uppaluri, MDPhD Bristol Myers Squibb Sookbin Woo @HNOPDFCI AACR

Such an honor to work with the incredibly dedicated team at JITC, lead by Dr. Romero. ❤️Love our mission. Efficiently and effectively sharing meaningful new discoveries to impact the lives of patients with cancer.

We are pleased to announce Dr. Kevin David as the new director of the Lymphoma Program RutgersCancerInstNJ! Dr. David leads a multidisciplinary team of experts who provide exceptional expertise, knowledge & skill with advanced therapies to treat #lymphoma . RWJBarnabas Rutgers RWJMedSchool

Center of Excellence for Cancer Immunology and Metabolism Rutgers Cancer Institute is seeking exceptional cancer immunologists jobs.rutgers.edu/postings/120928 & tumor immunology researchers jobs.rutgers.edu/postings/120926 to join our @TheNCI-Designated Comprehensive Cancer Center!

Welcome aboard Dr. In!!!!!
Rutgers Cancer Institute RWJBarnabas #LetsBeatCancerTogether